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ABSTRACT
Many signaling pathways have been shown to be involved in the formation of the
vascular system. Among them are the endothelial specific receptor families such as VEGF,
Ang/Tie, as well as other signaling pathways such as semaphorins, which are also involved,
in axonal guidance. It is known that the interaction between receptor tyrosine kinase, Tie2,
VE-Cadherin, and VE-PTP mediate endothelial cell quiescence and adhesion. However, the
structural basis of these interactions is not well understood. The aim of our study is to
characterize the binding interactions between these players. Another important part of
our study is describing the cross-talk between vasculature and nervous system by
characterizing the Neuropilin/Plexin/Semaphorin system.

VE-Cadherin along with

neuropilins plays an essential role by directing VEGF signals to the appropriate location
and coordinating the activation of downstream molecules.
We characterize the interaction between Tie2, VE-PTP and VE-Cadherin by (FRET)based proximity assay, fluorescence lifetime imaging, and co-immunoprecipitation assays.
Our data showed a consistent localization of the protein and FRET signal for Tie2 and VEPTP prior to ligand recognition. We showed the association between Tie2 and VE-Cadherin
complex by co-immunoprecipatation. However, our FRET data was not consistent. The
examination of VE-PTP and VE-Cadherin for association and localization of the protein
showed a very unique, mutually exclusive localization of the protein. Our study of
Neuropilin/Plexin/Semaphorin system showed changes in the protein localization, FRET
signal and morphology upon stimulation of HEK293 cells expressing Nrp/plexin with

Sema3D. In this system VE-Cadherin along with neuropilins plays an essential role by
directing VEGF signals to the appropriate location and coordinating the activation of
downstream molecules. The characterization of extracellular binding between Tie2, VEPTP, and VE-Cadherin, will help to better understand the molecular mechanisms of normal
and tumor angiogenesis to develop new anti-angiogeneic therapies.

Chapter 1
Introduction

1.1 Blood Vessel Development
The formation of the vascular system is one of the earliest and most important
events that occur in the developing embryo providing the growing organism with
oxygen and nutrients as well as removing the waste products. Vasculogenesis and
angiogenesis are two distinct processes that are required for the development of the
vascular system. Vasculogenesis is the process of the de novo formation of blood vessels
that consists of two distinct events: one is production of new endothelial cells in a
developing embryo and second is the formation of blood vessels in adult avascular
tissue area from precursor cells (hemangioblasts) which eventually differentiate into
vascular precursors (angioblasts). These angioblasts migrate, coalesce into cords and
assemble into a primary capillary plexus which expresses endothelial specific markers
such as vascular endothelial protein tyrosine phosphatase (VE-PTP), vascular
endothelia growth factor receptor 2 (VEGFR2), Tie1, Tie2, and vascular endothelium
(VE)-cadherin (Nawroth, 2002; Moser et al., 2012). Angiogenesis is the process of
formation of new blood vessels from already existing vessels by three mechanismsnon-sprouting (intussusceptive), sprouting, and stretching of existing vessels through
mechanical forces (looping). The difference between the non-sprouting and sprouting
mechanisms is that non-sprouting angiogenesis does not rely primarily on proliferation
of endothelial cells during embryonic development. In contrast, sprouting angiogenesis
depends on cell proliferation and occurs relatively slower (Makanya et al., 2008).
1

The formation of new blood vessels occurs through sprouting and looping.

The

understanding of looping mechanisms is very limited since it was only identified recently
(Kilarski et al., 2009).
In this dynamic network of blood vessels, endothelial cells that line the vascular wall
control the permeability of these blood vessel walls. The normal vascular permeability
contributes to normal angiogenesis, blood pressure control, as well as immune responses.
Abnormal increase in vascular permeability is often observed in many pathological
conditions and human diseases, such as brain stroke, allergy, inflammation, and tumorinduced angiogenesis (Prager et al., 2012).

1.2 Tumor Angiogenesis

It is easy to forget that cancer is not a single disease, but instead hundreds of
diseases that involve variety of molecules and signaling pathways. It starts when a cell
from any part of our body starts multiplying out of control for no good purpose and, if there
is no restraint, sooner or later it will create a mass of tissue called a tumor.
Angiogenesis and tumor progression are closely linked to each other.

Just as

embryo during development, tumor cells require a sufficient amount of blood vessels that
supply nutrients and oxygen for their growth and expansion (Hanahan et al., 2006). In the
2

absence of angiogenesis, tumor is an avascular mass, and can remain in the state of
dormancy for years. The tumor is referred to as the “angiogenic switch” (Bergers et al.,
2003) when it becomes angiogenic. This switch is initiated when the balance between proangiogenic and anti-angiogenic factors is in favor of the pro-angiogenic molecules such as
VEGF and Ang-2.

This unbalance is triggered by genetic mutations, metabolic or

environmental factors such as hypoxia (Carmeliet et al., 2000). In addition to genetic and
epigenetic changes, the “angiogenic switch” is a process that allows rapid tumor
progression. This increase in tumor vasculature can occur at any stage of tumor
development depending on the tumor type and the environment. The temporal and spatial
expansion of molecules that are involved in angiogenesis is not well regulated, leading to
an unorganized and functionally abnormal vasculature (Figure 1). The understanding of
how normal and tumor angiogenesis is regulated by these agniogenic factors is important
to deveolopment of anti-cancer drugs. For example anti-cancer drug, Bevacizumab (trade
name Avastin) is a humanized monoclonal antibody that inhibits the major pro-angiogenic
factor, vascular endothelial growth factor A (VEGF-A) (Heinke et al., 2012).

3

Figure 1: Tumor Angiogenesis. Following somatic mutation (1) a small collection of
tumor cells form that are avascular and remain dormant (2). The unbalance between
activators and inhibitors of angiogenesis results in “angiogenic switch” and release of
angiogenic factors (3) that stimulate rapid tumor growth via forming a mass of new blood
vessels (4).

4
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1.3 Endothelial Cell quiescence and Adhesion
Pathological conditions such as inflammation, hypoxia and thrombosis are
associated with increased vascular permeability.

Endothelial cells possess several

molecular mechanisms by which this permeability can be regulated. In mature vessels, the
endothelium is quiescent and cells adhere tightly to each other resulting in inhibition of
proliferation and a leak resistant vessel (Hordijk et al. 1999). Under these conditions cells
are less sensitive to growth factors such as VEGF, angiopoietin-1 (Ang-1) and fibroblast
growth factors (FGFs) and are protected from apoptosis.

This condition is called

endothelial cell quiescence and maintained at site of cell-cell junctions. The ability to
adhere is one of the most important characteristics of endothelial cells and regulated by the
proteins in adherens junctions (AJs) and tight junctions (TJs) (Taddei et al., 2008). Tight
junctions seal adjacent epithelial cells in a narrow band just beneath their apical surface
whereas adherens junctions provide strong mechanical attachments between adjacent cells
and responsible for contact inhibition. AJs are primarily composed of VE-cadherin, which
is capable of clustering and plays a vital role in endothelium integrity and regulates
vascular permeability (Montera-Balaguer et al., 2009). Structurally, VE-cadherin consists of
5 extracellular domains, a transmembrane domain, and a cytoplasmic tail. The short
6

cytoplasmic tail acts as a docking site for signal-transduction molecules and the external
domain regulates hemophilic interactions. VEGF is a fundamental regulator of vascular
permeability through downstream signaling mechanisms. It has been shown that the
binding of VEGF to its receptor VEGFR-2 activates the downstream phosphorylation of VEcadherin and causes it to translocate from of cell-cell junctions thereby decreasing
adhesive properties and enhancing permeability (Gavard et al., 2006). The primitive
vascular plexus is formed in the absence of VE-cadherin, however mice that are null for VEcadherin gene have major defects in vascular development, which results in embryo
lethality around 9.5-10.5 E (Montera-Balaguer et al., 2009). In addition to being linked to
VEGF receptors, VE-cadherin interacts with the endothelial receptor-type protein tyrosine
phosphatase VE-PTP through their extracellular domains and enhances its adhesive
function (Broermann et al., 2011). In the absence of VE-PTP, cell layer permeability
enhances and VE-cadherin adhesive function decreases (Nottebaum et al., 2008). The fact
that in VEGF stimulated cells VE-PTP dissociates from VE-cadherin, suggests that a precise
balance is needed between the VEGF and VE-PTP to control the endothelial barrier
integrity of VE-cadherin (Figure 2). These findings suggest that both VEGF and VE-PTP are
attreactive targets in treatment of pathological vascular permeability.

7

VE-PTP is found to associate with another cell surface membrane protein, Tie-2 that
binds to the cytoplasmic phosphatase domain of VE-PTP and it is shown to
dephosphorylate VE-PTP (Figure 2) (Baumer et al., 2006). Like VEFGRs, Tie-2 is a receptor
tyrosine kinase (RTK), which is vital to the formation of blood vessels during the
development and tumor angiogenesis. Structurally, RTKs consist of an extracellular ligand
binding domain, a single transmembrane helix, a juxtamembrane domain, a cytoplasmic
kinase domain and a C-terminal tail composed of multiple phosphorylatable tyrosines
(Hubbard et al., 2007). RTK’s have evolved many signaling mechanisms that consist of cell
surface protein receptors which serve to transduce signals from extracellular part of the
cell to the inside of the cell.

They initiate intacellular signals via their ability to

phosphorylate themselves and other cytoplamic proteins on tyrosine residues.

Thus,

understanding of how VE-PTP negatively regulates RTK’s has important therapeutic
implications.

8

Figure 2: Schematic Representation outlining the molecular mechanism regulating
the integrity of endothelial cell-cell contacts. Ang1 translocates Tie2 to cell-cell
contacts, which in turn, promotes VE-PTP translocation to cell junctions. Here at cell-cell
contacts, VE-PTP dephosphorylates Tie2 and VEGFR-2, which leads to inhibition of VEFGR2 phosphorylation of VE-Cadherin resulting in increased stability of endothelial cell
junctions and reduced permeability.
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Vestweber, D., Winderlich, M (2008). Cell adhesion dynamics at endothelial junctions: VECadherin as a major player.Trends in Cell Biology. Vol. 19. No1.
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1.4 The VEGF/VEGFR/Neuropilin/Plexin/Semaphorin system
The cardiovasculature and nervous system form a highly branched network
extending to every part of the body. VEGF signaling has crucial effects on cross-talk
between the two systems, but these signaling mechanisms must be regulated on many
levels to ensure the correct biological outcome (Heinke et al., 2012). Co-receptors such as
neuropilins (Nrp) and (VE)-cadherin direct VEGF signals to the appropriate location and
coordinates the activation of downstream molecules (18). Nrps (Nrp-1 and Nrp-2) are
single-pass transmembrane proteins with a large extracellular domain and a short
cytoplasmic domain that presents a PDZ binding site. Having a very short cytoplasmic
domain, Nrps are not able to transduce cell signals on their own and therefore, act as coreceptors and require plexins for signaling. They were initially characterized as nontyrosine kinase receptors that mediate axon guidance and neuronal development through
class-3 semaphorins. Now it is clear that Nrps are expressed by variety of cells including
EC and associate with normal and disease-associated blood vessel formation (Prahst et al.,
2008). The ability of Nrps to bind to two structurally and functionally unrelated ligands,
VEGF and semaphorins, suggests a dynamic interaction between angiogenesis and nervous
system. Semaphorins belong to a large family of cell-associated and secreted proteins
11

characterized by an extracellular N-terminal sema domain and a cysteine rich PSI (plexin,
semaphoring, and integrin) domain. They mainly function as chemorepellents that direct
axons away from the tissues marked by their expression though in some cases they act as
chemoattractants. Plexins are a large family for cell surface receptors for semaphorins.
Similarly, they contain a sema domain in the extracellular portion as well as (in general)
three copies of PSI domains and three IPT. Like Nrps, plexins are also widely expressed in
vasculature and nervous system.
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Chapter 2
Methods

2.1 Cell Manipulations and Transfections
Human Embryonic Kidney 293 ( HEK293) and human osteosarcoma cell line (U2OS)
cells were cultured in

Dulbecco’s Modified Eagle Medium (DMEM) (Invitrogen)

supplemented with 10% Fetal Bovine Serum (FBS) (Serum Source International) and 5%
Pen/Strep (Invitrogen).
antibiotics.

Transfections were performed in complete medium lacking the

Cells were consistently transfected at 70-90% using Lipofectamine 2000

(HEK293) or FuGENE HD (U2OS) and Opti-MEM (Invitrogen) according to the protocol
provided by Lipofectamine 2000 kit. In all co-expression experiments the ratio of each
construct was 1:1.

2.2 Cellular Imaging

For the analysis of interactions, in which two separate molecules are labeled with an
appropriate pair of fluorophores, an interaction can be shown by observing FRET (the two
molecules must be in close proximity (~10nm), the emission spectrum of the donor must
overlap with the excitation spectrum of the acceptor, and the emission dipole moment
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must not be orthogonal to the acceptor absorption dipole moment). By using fluorescence
imaging microscopy, one can visualize the location of green fluorescent proteins within a
living cell and follow the time course of the changes in FRET corresponding to cellular
events at a millisecond time resolution. The observation of such dynamic molecular events
in vivo provides vital insight into the action of biological molecules (Periasamy et al., 2005).

Cell imaging was performed 24-48 hours post-transfection using Zeiss Observer Z1
wide-field microscope equipped with violet HeNe (405 nm), Argon (458, 488, 514 nm),
green laser (561nm), orange (594 nm), red HeNe (633 nm). The system includes mercury
arc lamp excitation, a Zeiss AxioCamMRm CCD camera with 12-bit dynamic range, fully
automated xyz stage, a glycerin-immersion objective lens, 63x. In all experiments, the
conditions for live cells were 37°C and 5% CO2 humid atmosphere. Fluorophore-protein
fusions were imaged using excitation and emission wavelengths of 433 nm and 527 nm for
mTQ and sYFP2 respectively. The AOTF’s for 433 nm and 527 nm were set to 100% and
25% respectively to eliminate cross talk between the two channels. The FRET efficiency is
calculated using precision FRET (pFRET) algorithm which performs pixel-by-pixel signal
bleed-through (SBT) correction resulting in removal of donor and acceptor SBT on the
basis of matched fluorescence levels between double and single labeled specimens (21).
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The failure to detect FRET from a pair of labeled proteins may not always mean the
absence of interaction between them. Because this detection signal relies on the efficiency
of FRET and choosing a donor fluorophore that has a significant overlap with the acceptor
absorption is important.

When measuring living cells, one of the challenges is the

concentration dependence of the measured proteins, determination of which is practically
impossible in living cells. Another limitation of FRET is the intensity, which is more prone
to artifacts at weaker energy transfer signals. Lifetime imaging of the donor and acceptor
fluorophores offer significant improvement in sensitivity for determining the physical
interaction between the proteins.

Fluorescence lifetime imaging monitors lifetime

independent of local fluorophore concentrations and intensity but sensitive to
environmental conditions such pH and ion concentration (Gardella et al., 1993). One of the
limitations is the existence of different lifetimes which makes FRET determination using
FLIM very difficult in living cells.
For fluorescence lifetime imaging we used Zeiss LSM 510 META NLO multi-photon
laser scanning microscope (fixed stage upright) with internal (descanned) detectors
(including the META detector), two direct (non-descanned) detectors, a transmitted light
detector and a Becker & Hickl Fluorescence Lifetime Imaging system with 2 hybrid GaAsP
detectors (for FRET-FLIM). The system has four lasers: a Spectra-Physics Mia-Tai
15

broadband tunable Ti:sapphire laser (710-990 nm) for multi-photon imaging, as well as
Argon (458, 476, 488, 514 nm), 561 diode (561 nm), and red HeNe (633 nm). We analyzed
the lifetime data measured by Fluorescence Lifetime Imaging (FLIM) using SPCImage 3.2
(Becker & Hickl). This software analyzes the raw data using an exponential model function.
During the fitting process, the chi-square value between the data and the model function is
minimized.

2.3 Immunoprecipitation studies

HEK293 were seeded in 10 cm dishes and allowed to grow to 80-90% confluence.
Prior to transfection the media was changed to DMEM medium without penicillin. Cells
were transfected with Lipofectamine and Opti-MEM (Invitrogen) according to the protocol
provided by Lipofectamine 2000 kit with the appropriate vector DNA. After 48 hours the
transfected cells were washed briefly and gently with PBS.

Whole cell lysates were

harvested by adding lysis buffer (20 mM Hepes, 150 mM NaCl, 1 mM EDTA, 1% NP-40
detergent, 1 mM Sodium Orthovanadate, complete protease inhibitor (Roche), and 1.2
mg/mL Aprotinin (Sigma-Life Science). To get rid of cellular debris the cell lysate was
centrifuged for 10 minutes at 15, 000 rpm and the supernatant was collected for

16

immunoprecipatation.

Lysates were precipitated with Protein A agarose beads and

incubated with Tie2, VE-Cadherin or myc

antibodies (depending on the experiment

performed) overnight at 4C. After washing with HBST and HBS, bounded protein was
eluted from the beads by boiling in 2x Sample Buffer (10 mM Tris pH8.0, BM-t, 1%
bromophenol). Cell lysates and elutes from Protein A beads were separated by 10% SDSPAGE gel electrophoresis and electrotransferred to a nitrocellulose membrane (VWR). The
membrane was blocked with milk for 1 hour and then probed with primary monoclonal
antibody in TBST ( 10 mM Tris-HCl, 150 mM NaCl, and 0.05% Tween20) overnight. After a
15 minutes wash with TBST, the blot was probed with secondary antibody coupled to HRP
for 1 hour. The blot was developed with the chemiluminescent substrate (Pierce).

17

Results
Chapter 3
VE-PTP and Tie2 complex formation

To observe the localization and extracellular interaction between VE-PTP and Tie2,
we transiently expressed full length VE-PTP and VE-PTP lacking the phosphatase domain
with Tie2 lacking the tyrosine kinase domain in transfected human embryonic kidney cell
line (HEK293). The proteins were tagged with fluorophores and the localization was
monitored using a Zeiss Observer Z. 1 wide-field microscope coupled with fluorescence
resonance energy transfer (FRET)-based proximity assay. The Tie2 construct was fused
with a cyan fluorescent protein donor (mTurquoise-mTQ) to the carboxy termini in place of
the catalytic tyrosine kinase domain and a yellow fluorescent protein acceptor (sYFP2) was
linked to the carboxyl terminus of a full-length VE-PTP ectodomain construct (phosphatase
domain present). Figure 3.1 depicts that energy transfer between the donor (mTQ) and
acceptor (sYFP2) only occurs if the receptors are in close proximity (<10nm) which results
in emission of sYFP2 following excitation of mTQ. The FRET efficiency is calculated using
the precision FRET (pFRET) algorithm (developed by Ammasi Periasamy) which performs
pixel-by-pixel signal bleed-through (SBT) correction resulting in removal of donor and
acceptor SBT on the basis of matched fluorescence levels between double and single
18

labeled specimens (Elangovan et al., 2003). Figure 3.2 A illustrates a representative image
of fluorescence intensity and membrane localization of VE-PTP-full length (FL)-sYFP2 and
Tie2-mTQ. Based on our FRET-based proximity we are able to observe VE-PTP-FL and
Tie2 of an average FRET efficiency value of 15.2 ± 0.89 SEM. This FRET signal suggests that
the ectodomain of VE-PTP and Tie2 interact. We observed this association in the absence
of angiopoietin ligand demonstrating that VE-PTP-FL and Tie2 form complex prior to
ligand recognition. In addition to examining VE-PTP-FL, we also looked at the VE-PTPFRET (Figure 3.2 B) construct, which lacks the phosphatase domain. Similarly, the protein
was co-localized uniformly but did not interact based on the FRET efficiencies were
significantly lower. To make sure that the strong FRET signal between VE-PTP-FL and Tie2
was not due to over-expression, we co-expressed Tie2 receptor with the functionally
unrelated receptor Plexin-YFP shown in Figure 3.3 B and observed a 5.3% FRET efficiency
(negative control was generated by another member of the lab, Annamarie Dalton). These
findings suggest that the association between VE-PTP and Tie2 is specific and that FRET
efficiency observed is not due to overexpression and nonspecific interaction. For the
positive control Tie2-CFP construct was transiently transfected into HEK293 with Tie1YFP. This known association between Tie2 and Tie1 gave a very high FRET efficiency of
66.4±2.8 SEM (Figure 3.3B).
19

To confirm the association between Tie2 and VE-PTP with another technique we
performed Fluorescence Lifetime Imaging (FLIM) using SPCImage 3.2 software (Becker &
Hickl). When measuring living cells, one of the challenges is the concentration dependence
and different intensities of the fluorophores. However, fluorescence lifetime imaging
monitors lifetime independent of local fluorophore concentrations and intensity but
sensitive to environmental conditions such pH and ion concentration (Gardella et al.,
1993). The viability of live-cells is critical when using high intensity light sources such as
lasers.

Although, high speed time-gated FLIM reduces light that gets to cells,

measurements at very low light affect quantitative FLIM results. In two component FRET
system, non-radiative energy transfer occurs from donor to acceptor if they are in close
proximity and the fluorescence lifetime of the donor decreases. Figure 3.4 illustrates the
lifetime data for Tie2-mTQ alone (A) and Tie2-mTQ co-expressed with VE-PTP (B). In
average the lifetime of the double labeled cells does not decrease in our experiments (2.9
ns for both donor alone and donor in the presence of acceptor). Since numerically our
lifetime data did not confirm the interaction between Tie2 and VE-PTP, we ran both the
donor alone and the double labeled cells as monoexponential decay to show that the
lifetime distribution histogram clearly indicates that the donor in the presence of the
acceptor is not monoexponential decay.

This ”shoulder like” peak observed in the
20

histogram suggests the quenching of the donor and the possible occurrence of FRET
between VE-PTP and Tie2. In addition, we have made several attempts to show the
interaction between Tie2 and VE-PTP by co-immunoprecipitation assays. HEK293 cells,
which lack endogenous Tie2 and VE-PTP receptors, were transiently transfected with Tie2myc alone, VE-PTP-myc alone or a combination of two. As seen in Figure 3.5A, western
blotting of whole cell lysates with anti-myc antibodies demonstrate expression of Tie2, VEPTP and both in combination. The co-immunoprecipitation of Tie2, VE-PTP and both Tie2
and VE-PTP are shown in 3.5 B (total protein loaded in each lane was 1 mg).

All three

were IP’ed with Tie2 antibody and probed with anti-myc and therefore we expected to
observe Tie2 expression (lane 1) and no VE-PTP expression (middle lane). When both Tie2
and VE-PTP were co-expressed (lane 3), we expected to see two bands (one for Tie2 and
one for VE-PTP) since both constructs were fused to myc, IP’ed with Tie2 antibody and
probed with myc.

The relative ratio was determined and the calculated value was

arbitrarily set equal to 1.0 for VE-PTP alone. Values are graphically displayed below each
respective lane.
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Figure 3.1: Schematic Representation of FRET-based proximity assay of interaction
between VE-PTP and Tie2. The extracellular domains are fused to GFP variants, the VEPTP construct tagged with sYFP2 and Tie2 tagged with mTQ. Due to the proximity of the
receptors, upon excitation of mTQ at 433nm, non-radiative energy transfer occurs to
sYFP2, resulting in sYFP2 emission.
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Figure 3.2: In vivo FRET images of VE-PTP-Tie2 interaction. Tie2-mTQ construct was transiently
transfected into HEK293 with VE-PTP-FL-sYFP2 (A) or VE-PTP-FRET-sYFP2 (B). FRET efficiency
values were determined within the regions of interest (ROI) and averaged with ±SEM.
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Figure 3.3: In vivo FRET images positive and negative controls. A) Tie2-CFP construct was
transiently transfected into HEK293 with Tie1-YFP as a positive control. B) Tie2-mTQ and
Plexin-YFP were transiently transfected into HEK293 as a negative control. FRET efficiency
values were determined within the regions of interest (ROI) and averaged with ±SEM.
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40

Figure 3.4: The lifetime data of Tie2-mTQ and VE-PTP. Tie2-mTQ alone (A) and Tie2-mTQ coexpressed with VE-PTP (B) measured by Fluorescence Lifetime Imaging (FLIM) using SPCImage
3.2 software (Becker & Hickl).
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Figure 3.5: Cell Lysate and Immunoprecipitation of Tie2 and VE-PTP. (A) Cell Lysate
of Tie2 alone, VE-PTP alone and both combined. (B) HEK293 cells were transfected with
Tie2-myc alone, VE-PTP-myc alone or both proteins combined, harvested and lysates
probed with anti-myc. The relative ratio was determined and the calculated value was
arbitrarily set equal to 1.0 for VE-PTP alone. Values are graphically displayed below each
respective lane.
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Chapter 4
VE-Cadherin and Tie2 complex formation

To observe the localization and extracellular interaction between VE-Cadherin and
Tie2 in vivo similar FRET assay as described above for VE-PTP and Tie2 was used. Both
proteins were linked to GFP variant fluorophores to visualize the localization. The Tie2
construct was fused with a cyan fluorescent protein donor (mTurquoise-mTQ) and a
yellow fluorescent protein acceptor (Venus) was linked to the VE-Cadherin construct. Both
proteins were expressed in

transiently transfected HEK293 and imaged to look for the

occurrence of FRET. The FRET efficiency is calculated similarly using precision FRET
(pFRET) algorithm. Couple different scenarios were observed with this complex. We saw a
co-localization with FRET efficiency of 14.9±1.3 SEM which suggests a possible association
between of VE-Cadherin and Tie2. However, we also observed the protein not co-localizing
in cells co-expressed with these two constructs. Figure 4.1 illustrates the protein colocalizing with FRET signal of 14.9±1.3 SEM in not a confluent dish (A) or at cell-cell
junctions (B). We also saw the protein not co-localizing at either confluent (data not
shown) or cell-cell junction (C). Our studies in U2OS suggested no interaction between VECadherin and Tie2 since the protein did not co-localize and therefore there was no FRET
signal (4.1D). Figure 4.2 illustrates the lifetime data for Tie2-mTQ alone (A) and Tie2-mTQ
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co-expressed with VE-Cadherin-Venus (B). In average the lifetime does not decrease in our
experiments (2.9 ns for both donor alone and donor in the presence of the acceptor).
However, although we ran both the donor alone and the double labeled cells as
monoexponential decay, the lifetime distribution histogram clearly shows that the donor in
the presence of the acceptor is not monoexponential decay. This ”shoulder like” peak
observed in the histogram suggests the quenching of the donor and the possible occurrence
of FRET between VE-Cadherin and Tie2. We were able to show the interaction between
VE-Cadherin and Tie2 by co-immunoprecipitation assays shown in Figure 4.3. Telomeraseimmortalized human microvascular endothelial (TIME) cells which has endogenous VECadherin and Tie2 were harvested, lysed, and probed with anti-Tie2 (4.2A) As expected,
we were able to observe Tie2 expression in whole cell lysate (lane 3) and no expression in
the negative control (middle lane). Lane 1 was IP’ed with VE-Cadherin antibody, probed
with Tie2. The reciprocal was performed with anti-VE-Cadherin antibody. Similarly, we
were able to express VE-Cadherin (lane 1) and observed no expression in the negative
control (middle lane).

The relative ratio was determined and the calculated value was

arbitrarily set equal to 1.0 for the negative control. Values are graphically displayed below
each respective lane (total protein loaded for IP was 1mg).
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Figure 4.1: In vivo FRET images of VE-Cadherin-Venus with Tie2 interaction. Tie2mTQ construct was transiently transfected into HEK293 with VE-Cadherin-Venus showing
co-localization of the protein on the cell membrane (A) or at cell-cell junction (B) or no colocalization (C).

Tie2-mTQ construct was transiently transfected into U2OS with VE-

Cadherin-Venus showing no co-localization (D). FRET efficiency values were determined
within the regions of interest (ROI) and averaged with ±SEM.
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Figure 4.2: Lifetime data of Tie2 and VE-Cadherin. Tie2-mTQ alone (A) and Tie2-mTQ coexpressed with VE-Cadherin-Venus (B) measured by Fluorescence Lifetime Imaging (FLIM) using
SPCImage 3.2 software (Becker & Hickl).
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Figure 4.3: Immunoprecipitation of VE-Cadherin and Tie2. TIME cells were harvested, lysed,
and probed with anti-Tie2 (A) and the reciprocal was performed with anti-VE-Cadherin (B). The
relative ratio was determined and the calculated value was arbitrarily set equal to 1.0 for the
negative control. Values are graphically displayed below each respective lane.
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Chapter 5
VE-Cadherin and VE-PTP complex formation
We performed similar assay to examine the localization and extracellular
interaction between VE-Cadherin and VE-PTP in vivo. We examined few differently tagged
constructs of VE-PTP and VE-Cadherin and all showed a very unique mutually exclusive
localization of the protein. VE-PTP-FL-mTQ was co-expressed with VE-Cadherin-Venus
showing mutually exclusive localization of the protein when the cells are confluent (5.1 A)
and mutually exclusive behavior in isolated cells (5.1 B). This unusual mutually exclusive
localization of the protein was also observed with VE-Cadherin-mTQ co-expressed with VEPTP-FL-sYFP2 and VE-FRET-sYFP2 (data not shown). Figure 5.2 illustrates the lifetime
data for VE-PTP-FL-mTQ alone (A) and VE-PTP-FL-mTQ co-expressed with VE-CadherinVenus (B). In average the lifetime does not decrease in our experiments (2.8 ns for bot
donor alone and donor in the presence of the acceptor). However, although we ran both
the donor-acceptor and the donor alone as monoexponential decays, the lifetime
distribution histogram clearly shows that the double labeled specimen is not
monoexponential decay.
In addition, we made several attempts to co-express all three, VE-PTP, VE-Cadherin,
and Tie2 in HEK293. VE-PTP-FL-sYFP2 and VE-Cadherin-mTQ were co-expressed with
Tie2 fused to myc. We observed mutual exclusive localization of the protein as shown in
figure 5.3 but unfortunately Tie2-myc appeared to be toxic to cells and we were unable to
obtain statistically enough data to fully characterize the behavior of the protein.
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Figure 5.1: In vivo FRET images of VE-Cadherin-Venus and VE-PTP interaction. VECahdherin-Venus construct was transiently transfected into HEK293 with VE-PTP-FL-mTQ
showing mutually exclusive localization of the protein in a confluent dish (A) or mutually
exclusive behavior in isolated cells (B) FRET efficiency values were determined within the
regions of interest (ROI) and averaged with +/- SEM.
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Figure 5.2: The lifetime data of VE-PTP and VE-Cadherin. VE-PTP-mTQ alone (A) and VE-PTPmTQ co-expressed with VE-Cadherin-Venus (B) measured by Fluorescence Lifetime Imaging
(FLIM) using SPCImage 3.2 software (Becker & Hickl).
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Figure 5.3: In vivo FRET images of VE-Cadherin, VE-PTP and Tie2 interaction. VE-PTP-FL-sYFP2,
VE-Cadherin-mTQ and Tie2-myc constructs were transiently transfected into HEK293 showing
mutually exclusive localization of the protein.
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Chapter 6
Neuropilin/Plexin/Semaphorin system
We tested several constructs of Nrps and Plexins with various linker lengths to
obtain the best FRET efficiency signal in HEK293. In addition to difference in linker size,
we tested different members of PlexinA family. Neuropilin-1 with relatively small linker
size of five residues and Plexin-A1 with nine amino acid residues gave the most reliable
results. Nrp-1 tagged with mYFP was co-expressed with PlexinA1 tagged with mCFP in
HEK293. We observed a co-localization of the protein with FRET efficiency 13.8±5.3SEM
HEK293 cells expressing Nrp-1 and PlexinA1 were induced with Semaphorin3D (Sema3D)
and the images were taking every five minutes for one hour. The role of Sema3D on this
Nrp/Plexin complex is not well understood. Based on evidence provided by studies on the
nature of Nrp-1/Plexin-A1 complex formation, we hypothesized that Sema3D has the
ability to change the morphology of the cells. Class 3 semaphorins are known to have a
high-potency growth cone-collapsing activity in neuronal cells and morphologic changes in
nonneuronal cells ( Luo et al., 1993; Tamagnone et al., 1999). Based on our observations,
Sema3D caused expansion in size and rounding up of Nrp-1/PlexinA1 expressing cells. In
addition, we observed the protein dissociation and clustering in some parts of the cells as
shown in figure 6.1. This morphological change was observed over the first 5-10 minutes
after the ligand addition. The addition of Semaphorin3D also induced FRET signal in the
two experiments we performed. However, we did not average this increase since in one
experiment the FRET signal increased by two fold and in the other one by six fold. The
FRET signal before adding the ligand was significantly different for both experiments as
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well. From our experiments it is clear that addition of Sema3D to Nrp-1/Plexin complex is
able to mediate the morphologic changes in nonneuronal HEK293 cells.
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Figure 6:

In vivo FRET imaging of Nrp-1 and PlexinA1 complex induced with

Semaphorin 3D in HEK293. Nrp-1-mYFP construct was transiently transfected into
HEK293 with PlexinA1-mCFP. Semaphorin 3D was added and images were taken every
five minutes for 60 minutes (the images of every 20 minutes are shown).
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Chapter 7
Conclusions
Fluids, cells, nutrients and oxygen are normally exchanged between the blood
compartments and the surrounding tissues. In this dynamic network, endothelial cells that
line the vascular wall control the permeability of these blood vessel walls. The normal
vascular permeability contributes to normal angiogenesis, blood pressure control, as well
as immune responses. Abnormal increase in vascular permeability is often observed in
pathological conditions and human diseases, such as tumor-induced angiogenesis,
inflammation, allergic reaction, and brain stroke. This vascular permeability is regulated
by adhesive molecules and receptors that co-localize at cell-cell contacts (Kilarski at el.,
2009).
What happens when the adhesion molecules meet the receptors? Receptors such as
RTK’s are located on the cell surface helping cells to communicate with their environment
and carry signals to the intracellular machinery. It used to be known that the binding of
ligands triggers the activation of the receptors, now it is clear that cell adhesion molecules
significantly contribute to this activation process (Hanahan at el., 1996).

The

understanding of this tight collaboration between cell adhesion molecules and RTK’s has
important therapeutic implications.
It has been shown that receptors such as VE-PTP and Tie2 regulate permeability
through its interaction with an adhesive molecule VE-Cadherin. Ang-1 is an important
player in this scenario by translocating Tie2 to cell-cell contacts, which, in turn, promotes
VE-PTP translocation from vesicular compartments in the cell, to the cell-cell contacts. Here
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at cell-cell contacts, VE-PTP dephosphorylates Tie2 and VEGFR-2 which leads to inhibition
of VEFGR-2 phosphorylation of VE-Cadherin and inhibition of EC proliferation. The clear
picture of the role of these players in normal angiogenesis and tumor angiogenesis is still
unclear. Further investigation of VE-PTP, VE-Cadherin and Tie2 will reveal possible
applications in treatments of angiogenic diseases (Winderlich at el., 2009).
It is known that VE-PTP interacts with Tie2 primarily in contacting cells decreasing
permeability. For ease of transfection and cellular imaging, we have done most of our
experiments in HEK293 cells based upon their lack of endogenous Tie2 and VE-PTP
Vestweber at el., 2008). Our data shows the association between VE-PTP and Tie2 in
HEK293 with FRET efficiency of 15.2 ± 0.89 SEM, compared to the negative control, which
gave a result of 5.3% FRET efficiency. This FRET signal leads us to believe that the
ectodomain of VE-PTP and Tie2 interact. As discussed above Ang1 translocates Tie2 to
cell-cell contacts and therefore Ang1-activated Tie2 decrease permeability by introducing
more VE-PTP to the intercellular junctions. We observed VE-PTP-Tie2 association in the
absence of Ang1 demonstrating that VE-PTP-FL and Tie2 form a complex prior to ligand
recognition. Our positive control (co-expressed Tie1 and Tie2) gives a very high FRET
efficiency of 66.4±2.8 SEM (Figure 3.3B) indicating that further biochemical and
biophysical studies have to be done to characterize the interaction between the Tie2 and
VE-PTP ectodomains. One of the essential future directions is to show the formation of VEPTP-Tie2 complex in endothelial cells, which express the proteins endogenously.
VE-PTP-Tie2 complex formation was also shown using Fluoresecence Lifetime
Imaging Microscopy (FLIM) which is a powerful tool to map protein-protein interactions in
living specimens. As discussed in chapter1 fluorescence lifetime is unaffected by the
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change in probe concentration or excitation intensity. However, FLIM is a technically
challenging technique because it is influenced by any small changes in the cellular
environment and the existence of different lifetimes makes FRET determination using FLIM
very difficult in living cells. Although, it is expected to observe the decrease of lifetime in
the presence of the acceptor, we were unable to show that numerically. However, the
lifetime distribution histogram clearly showed the quenching of the donor in the presence
of the acceptor, which indicates the possible FRET occurrence between VE-PTP and Tie2.
Several attempts were made to detect Tie2-VE-Cadherin binding by transiently
expressing

them

in

HEK293

and

performing

co-immunoprecipitation

assays.

Unfortunately, despite repeated attempts in changing the concentrations, using different
constructs and different antibodies, we were unable to show a clear indication of binding of
these two receptors in transient system. One of the most promising data was obtained
when both Tie2 and VE-PTP were fused to myc and we were able to see two bands (one for
Tie2 and one for VE-PTP) when both were transiently overexpressed in HEK293 and coimmunoprecipitated (Figure 3.5).
Among all the mechanisms that regulate vascular permeability of endothelial cells,
tyrosine phosphorylation plays an essential role. It is generally accepted that this tyrosine
phophorylation of VE-Cadherin is observed in weak junctions, which usually leads to
pathological conditions. The extent of this phosphorylation is declined when cells reach
confluency (Lambugnani et al., 1997). However, the exact mechanism of VE-Cadherin
phosphorylation has not been fully clarified. The extracellular interaction between VE-PTP
and VE-Cadherin has been shown (Nawroth et al., 2002). Surprisingly, our data showed a
very unique mutually exclusive interaction (Figure 5.1A and B) in both confluent and
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isolated cells. We believe that this relationship between tyrosine phosphorylation and AJ
opening had an effect on our data because we observed localization and no-localization in
both confluent and not very confluent cells when with VE-Cadherin and Tie2 complex. Our
FRET data of this complex showed a co-localization with FRET efficiency of 14.9±1.3 SEM
and a significant part of our data showed no co-localization of the protein in both HEK293
and U2OS cell lines. Similarly, the numeric part of the lifetime data was not promising but
the lifetime distribution histogram clearly showed the quenching of the donor in the
presence of the acceptor and possible occurrence of FRET between VE-Cadherin and Tie2.
For immunoprecipitation studies, crude protein lysates were prepared from TIME cells
expressing endogenous Tie2 and VE-Cadherin. As shown in Figure 4.3 when used for
immunoprecipitation, we were able to precipitate endogenous Tie2 and VE-Cadherin.
In addition, we made several attempts to co-express all three, VE-PTP, VE-Cadherin,
and Tie2 in HEK293. VE-PTP-FL-sYFP2 and VE-Cadherin-mTQ was co-expressed with Tie2
fused to myc. We observed mutual exclusive localization of the protein (Figure 5.3) but
unfortunately Tie2-myc appeared to be toxic to cells and we were unable to obtain
statistically enough data to fully characterize the protein behavior. The failure to detect
FRET from a pair of labeled proteins may not always mean the absence of interaction
between them. Mainly because we are working with overexpressed system and there are
many factors that have effects on our data such as the transfection efficiency, fluorophore
concentrations, intensity, environment and etc.
Another focus of our studies was to better understand the Neuropilin/Plexin/
Semaphorin system. This signaling system is involved in the regulation of various
developmental events including axonal extension, cell migration in the nervous system,
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growth of endothelial cells, and cardiac development. Neuropilins are known for their
ability to bind to class 3 semaphorins using plexin as a co-receptor to activate downstream
signal transduction cascades (Capparuccia at el., 2009). Not much is known about the
effect of Sema3D on Nrp/plexin complex. The aim of our study is to characterize the
protein localization, morphological changes and FRET signal upon of this complex upon
stimulation with Sema3D. We first examined several constructs of Nrp and plexin with
various linker lengths to determine the optimal pair that gave the best FRET efficiency
signal (13.8%±5.3 SEM, this is a negative control with no Sema added). HEK293 cells
expressing Nrp-1 and PlexinA1 showed a morphology change after addition of Semaphorin
3D. Based on our observations, Sema3D caused expansion in size and rounding up of Nrp1/PlexinA1 expressing cells.

In addition, we observed that the protein dissociated and

clustered in some parts of the cells and the FRET signal in the two experiments we
performed was 22.5%±4.5 SEM upon stimulation with Sema3D. (Figure 6). Based on our
observations Sema3D has effects on the association of Nrp and plexin. As we discussed in
the introduction Nrps have the ability to bind to both semaphorins and VEFG, which are
two structurally and functionally, unrelated ligands suggesting a tight collaboration
between angiogenesis and the nervous system. In this process VE-Cadherin along with
neuropilins plays an essential role by directing VEGF signals to the appropriate location
and coordinating the activation of downstream molecules. Further studies are needed to
investigate the Nrps/Plexin complex behavior upon addition of semaphorins and VEGF.
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